Authors:
Gilligan, PJ
Baldauf, C
Cocuzza, A
Chidester, D
Zaczek, R
Fitzgerald, LW
McElroy, J
Smith, MA
Shen, HSL
Saye, JA
Christ, D
Trainor, G
Robertson, DW
Hartig, P
Citation: Pj. Gilligan et al., The discovery of 4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-alpha]-pyrimidine: A corticotropin-releasing factor (hCRF(1)) antagonist, BIO MED CH, 8(1), 2000, pp. 181-189
Authors:
He, LQ
Gilligan, PJ
Zaczek, R
Fitzgerald, LW
McElroy, J
Shen, HSL
Saye, JA
Kalin, NH
Shelton, S
Christ, D
Trainor, G
Hartig, P
Citation: Lq. He et al., 4-(1,3-dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2,4-dichlorophenyl)-pyrazolo[1,5-a]-1,3,5-triazine: A portent, orally bioavailable CRF1 receptor antagonist, J MED CHEM, 43(3), 2000, pp. 449-456
Authors:
Morgan, E
Ostrum, RF
DiCicco, J
McElroy, J
Poka, A
Citation: E. Morgan et al., Effects of retrograde femoral intramedullary nailing on the patellofemoralarticulation, J ORTHOP TR, 13(1), 1999, pp. 13-16